MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fcimb.2025.1717909

Медицинская библиотека · Frontiers in cellular and infection microbiology · 2026

From anonymity to stardom: history of nontuberculous mycobacterial disease in humans.

Sharma Surendra Kumar, Upadhyay Vishwanath, Mohan Alladi

СтатьяОбзорИсторическая статьяПеревод в очереди

Аннотация

Until recently, nontuberculous mycobacteria (NTM) were not considered as human pathogens. Their nomenclature has evolved over several years, until 1971 when finally named as NTM, which is universally accepted now. Because of continuously evolving diagnostic methods, several new species/subspecies of NTM were identified. Presently, nearly 200 NTM species have been reported. Similar to tuberculosis (TB), NTM are known to involve both pulmonary and extrapulmonary organs. Diagnosis of NTM disease is quite cumbersome and is primarily based on their growth characteristics on solid and liquid cultures. Biochemical testing was the mainstay of NTM diagnosis and species identification in the past, which was often erroneous. Recently, molecular tests like line probe assay, targeted, and whole genome sequencing have become available for rapid and accurate diagnosis. Isolation and identification of NTM species/subspecies alone do not warrant treatment. After ascertaining clinical relevance, virulence of NTM species, and evidence for clinical and radiological progression, the decision to administer treatment is taken. Multiple drugs are often administered for 12 months after sputum culture conversion, except in M. kansasii, and M. szulgai, where this constitutes the total treatment duration, with careful follow‑up for relapse and exogenous new infection. The present review traces the history, evolution of classification of NTM, strides made in the diagnosis and treatment of NTM disease. By integrating these historical lessons on taxonomy, culture phenotypes, genotypes and diagnostic pitfalls with contemporary molecular tools and species/subspecies specific treatment regimens, current practice enables more precise, timely, and patient-centered management of NTM disease.

Для цитирования: Sharma Surendra Kumar, Upadhyay Vishwanath, Mohan Alladi. From anonymity to stardom: history of nontuberculous mycobacterial disease in humans.. Frontiers in cellular and infection microbiology. 2026. DOI: 10.3389/fcimb.2025.1717909.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.